Navigation Links
Stem cell research

A team of scientists, based in UK, have grown human nerve cells in the lab, in the first successful attempt to control the development of embryonic stem cells. Their work is a major step towards the production of replacement tissues for treating neurodegenerative conditions like Parkinson's and Alzheimer's disease.

Researchers worldwide have been in heavy competition over the past few years to capture the potential of embryonic stem cells - a kind of 'template' cell - by directing their differentiation into a specialised cell such as a nerve or muscle cell. The Britain-based team, headed by Dr Martin Cliffer,University's Institute of Reproduction and Development together with colleagues in Israel and Singapore, is the first to succeed. Their results are reported in this week's issue of Nature biotechnology.//

Great hope has been placed in stem cells because their ability to grow into any type of cell means they could be used to develop new tissues for disease treatment, and possibly organs for transplantation. If nerve cells can be grown from scratch in the lab, for example, they may eventually be able to be injected into the brains of people with Alzheimer's disease to replace degenerating tissue.

"Because human embryonic stem cells represent, in principle, an indefinitely renewable source of any type of human cell, they have major applications in research and medicine," said a team member Professor Alan Trounson."It must be noted that almost all of the wide-ranging potential applications of [embryonic stem] cell technology in human medicine are based on the assumption that it will be possible to grow [embryonic stem] cells on a large scale, to introduce genetic modifications into them, and to direct their differentiation," the researchers wrote. Their success in maintaining stem cell lines in culture for an extended period, isolating early-stage nerve cells and nurturing them into mature nerve cells, is an important demonstrat ion that the speculative potential of stem cells can actually be harnessed in practice.


'"/>




Related medicine news :

1. Stem cell research- now Nobel Laureates join the debate
2. Spouses and other partners lower blood pressure says new research
3. Ecstasy shrinks brain!!-researchers unveil the secrets of MDMA.
4. Gene researchers make Malaria-resistant mosquito
5. Novel research on liver cancer
6. Space research leads to needle-free blood tests
7. SARS research confirms link to animals
8. New turn in stem cell research
9. Calcium Supplementation May Not Actually Prevent colon cancer say researchers
10. AIDS research and genetics...
11. Researchers at Cornell University as been reported using research fund by false claims
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... ... October 12, 2017 , ... ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 ... characterized by frequent cessation in breathing. Oral appliances can offer significant relief to ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has ... today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula ... the highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, ...
(Date:10/12/2017)... MD (PRWEB) , ... October 12, 2017 , ... The ... of Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual ... – 8. , In honor of Morris F. Collen, a pioneer in the field ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: , ... to enable prevention of a major side effect of chemotherapy in children. Cisplatin ... patients. For cisplatin, hearing loss is FDA listed on-label as a dose limiting ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a ... of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners ... October 11, 2017. , The annual award competition recognizes editorial and design excellence across ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, Inc. ... earnings conference call and webcast on Friday, November 3, ... (EDT) and ending at approximately 8:30 a.m. (CDT) / ... the company,s 2017 financial performance and guidance for 2018, ... initiatives to enhance operational performance, and long-range financial outlook ...
(Date:9/27/2017)... and NEW YORK , Sept. 27, 2017  DarioHealth ... and big data solutions, today announced that its MyDario product is expected ... local TV listings for when The Dr. Oz Show airs in your ... The nine-time Emmy ... ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
Breaking Medicine Technology: